Update on antidepressant use during breastfeeding

Canadian Family Physician

Volumn 59, Issue 6, 2013, Pages 633-634

  Chad, Lauren ^a   Pupco, Anna ^c   Bozzo, Pina ^c   Koren, Gideon ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; DESVENLAFAXINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ARTICLE; BREAST FEEDING; BREAST MILK; DRUG EXPOSURE; DRUG MILK LEVEL; FEEDING DISORDER; HUMAN; IRRITABILITY; PUERPERAL DEPRESSION; PUERPERIUM; SIDE EFFECT; SLEEP DISORDER;

ANTIDEPRESSIVE AGENTS; BREAST FEEDING; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; MILK, HUMAN;

EID: 84879677205     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Gaynes BN, Gavin N, Meltzer-Brody S, Lohr KN, Swinson T, Gartlehner G, et al. Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess (Summ) 2005;119:1-8.
2. Moehler E, Brunner R, Wiebel A, Reck C, Resch F. Maternal depressive symptoms in the postnatal period are associated with long-term impairment of mother-child bonding. Arch Womens Ment Health 2006;9(5):273-8. Epub 2006 Sep 8.
3. Grace SL, Evindar A, Stewart DE. The effect of postpartum depression on child cognitive development and behavior: a review and critical analysis of the literature. Arch Womens Ment Health 2003;6(4):263-74.
4. Lam RW, Kennedy SH, Grigoriadis S, McIntyre RS, Milev R, Ramasubbu R, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord 2009;117(Suppl 1):S26-43. Epub 2009 Aug 11.
5. Health Canada [website]. Nutrition for healthy term infants: recommendations from birth to six months. Ottawa, ON: Health Canada; 2012. Available from: www.hc-sc.gc.ca/fn-an/nutrition/infant-nourisson/recom/index- eng.php. Accessed 2013 Apr 23.
6. Bennett PN. Use of the monographs on drugs. In: Bennett PN, editor. Drugs and human lactation. 2nd ed. London, UK: Elsevier; 1996. p. 70-3.
7. Ito S. Drug therapy for breast-feeding women. N Engl J Med 2000;343(2):118-26.
8. Berle JO, Spigset O. Antidepressant use during breastfeeding. Curr Womens Health Rev 2011;7(1):28-34.
9. Rampono J, Teoh S, Hackett LP, Kohan R, Ilett KF. Estimation of desvenlafaxine transfer into milk and infant exposure during its use in lactating women with postnatal depression. Arch Womens Ment Health 2011;14(1):49-53. Epub 2010 Oct 7.
10. Ilett KF, Watt F, Hackett LP, Kohan R, Teoh S. Assessment of infant dose through milk in a lactating woman taking amisulpride and desvenlafaxine for treatment-resistant depression. Ther Drug Monit 2010;32(6):704-7. DOI:10.1097/FTD.0b013e3181f88f70.
11. Weissman AM, Levy BT, Hartz AJ, Bentler S, Donohue M, Ellingrod VL, et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry 2004;161(6):1066-78.